إعلان
إعلان
IMCR
Immunocore Holdings plc - ADR
33.13
USDبرعاية
-0.63
-1.88%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
33.30
+0.17
+0.53%
تقارير أرباح IMCR
النسبة الإيجابية المفاجئة
IMCR تفوق 12 من 20 آخر التقديرات.
60%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$109.21M
/-$0.24
التغير الضمني من Q3 25 (Revenue/ EPS)
+5.32%
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
+29.93%
/-48.94%
Immunocore Holdings plc - ADR earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, IMCR reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.26 USD, resulting in a 100.00% surprise. Revenue reached 103.69 مليون, compared to an expected 102.19 مليون, with a 1.47% difference. The market reacted with a +2.58% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 19 المحللين forecast an EPS of -0.24 USD, with revenue projected to reach 109.21 مليون USD, implying an -- of --% EPS, and زيادة of 5.32% in Revenue from the last quarter.
الأسئلة الشائعة
What were Immunocore Holdings plc - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Immunocore Holdings plc - ADR reported EPS of $0.00, beating estimates by 100%, and revenue of $103.69M, 1.47% above expectations.
How did the market react to Immunocore Holdings plc - ADR's Q3 2025 earnings?
The stock price moved up 2.58%, changed from $30.80 before the earnings release to $31.59 the day after.
When is Immunocore Holdings plc - ADR expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Immunocore Holdings plc - ADR's next earnings report?
Based on 19
المحللين, Immunocore Holdings plc - ADR is expected to report EPS of -$0.24 and revenue of $109.21M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان